RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.48
-0.02 (-4.40%)
Open$0.48
Previous Close$0.50
Day High$0.53
Day Low$0.48
52W High$17.20
52W Low$0.26
Volume—
Avg Volume23.3K
Market Cap6.29M
P/E Ratio—
EPS$-1.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+2,477.1% upside
Current
$0.48
$0.48
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 8.56M | 9.00M |
| Net Income | 1.57M | 1.65M | 1.70M |
| Profit Margin | 18.8% | 19.3% | 18.9% |
| EBITDA | 1.64M | 1.79M | 2.00M |
| Free Cash Flow | 1.45M | 1.55M | 1.35M |
| Rev Growth | +3.9% | +2.6% | +16.0% |
| Debt/Equity | 0.31 | 0.31 | 0.40 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |